$7.5MVenture, 28 January 2026
SAFE proceeds will move SOOPR through preclinical and clinical studies.
- Amount
- $7.5M
- Stage
- Venture
- Announced
- 28 January 2026
- Use of funds
- SAFE proceeds will move SOOPR through preclinical and clinical studies.
- Checked
- Announced by the company
- Source
- Elysium Therapeutics: $7.5 Million SAFE Round Raised pulse2.com